| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 802,794 | 631,729 | 571,408 | 635,832 | | Cost of Revenue | 662,277 | 531,269 | 521,139 | 645,589 | | | Gross Profit | 140,517 | 100,460 | 50,269 | (9,757) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 56,444 | 50,278 | 45,106 | 46,256 | | Non Recurring | 13,385 | 8,709 | 21,402 | 107,742 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 70,688 | 41,473 | (16,239) | (163,755) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,212 | 2,354 | 2,198 | (5,535) | | Earnings Before Interest And Taxes | 71,900 | 43,827 | (14,041) | (169,290) | | Interest Expense | 11,440 | 12,097 | 12,655 | 13,484 | | Income Before Tax | 60,460 | 31,730 | (26,696) | (182,774) | | Income Tax Expense | 2,628 | 967 | (3,773) | (28,327) | | Minority Interest | (15,282) |
-
|
-
| 11,009 | | | | Net Income From Continuing Ops | 57,832 | 30,763 | (22,923) | (143,438) | | | Non-recurring Events | | Discontinued Operations | (337) | (37,085) | (364) | (16) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,213 | (6,322) | (23,287) | (143,454) | | Preferred Stock And Other Adjustments | 4,618 | (6,638) | 2,020 |
-
| | | Net Income Applicable To Common Shares | $46,831 | ($12,960) | ($21,267) | ($143,454) |
|
0.22% Nasdaq 
Income Statement
